• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一例阿达木单抗相关的间质性肺炎合并类风湿关节炎。

A case of adalimumab-associated interstitial pneumonia with rheumatoid arthritis.

机构信息

Department of Rheumatology, Ome Municipal General Hospital, 4-16-5 Higashi-Ome, Ome, Tokyo 198-0042, Japan.

出版信息

Mod Rheumatol. 2010 Oct;20(5):518-21. doi: 10.1007/s10165-010-0308-4. Epub 2010 May 14.

DOI:10.1007/s10165-010-0308-4
PMID:20467775
Abstract

A 64-year-old woman with rheumatoid arthritis (RA) began to complain of recurrent non-productive cough 5 months after starting adalimumab. The chest radiograph and high-resolution computed tomographic findings revealed diffuse ground-glass attenuation. Her clinical course suggested that interstitial pneumonia (IP) may have been induced by adalimumab, and she was successfully treated with a medium dose of corticosteroid. This case indicates that adalimumab-associated IP should be considered if a RA patient develops non-productive cough following adalimumab therapy.

摘要

一位 64 岁的类风湿关节炎(RA)女性患者,在开始使用阿达木单抗治疗后 5 个月开始反复出现无痰干咳。胸部 X 线片和高分辨率计算机断层扫描(HRCT)结果显示弥漫性磨玻璃影。她的临床过程提示可能是阿达木单抗引起的间质性肺炎(IP),经中剂量皮质类固醇治疗后病情缓解。该病例表明,如果 RA 患者在阿达木单抗治疗后出现无痰干咳,应考虑阿达木单抗相关间质性肺炎。

相似文献

1
A case of adalimumab-associated interstitial pneumonia with rheumatoid arthritis.一例阿达木单抗相关的间质性肺炎合并类风湿关节炎。
Mod Rheumatol. 2010 Oct;20(5):518-21. doi: 10.1007/s10165-010-0308-4. Epub 2010 May 14.
2
Adalimumab-induced interstitial pneumonia with an improvement of pre-existing rheumatoid arthritis-associated lung involvement.阿达木单抗诱发的间质性肺炎,同时既往存在的类风湿关节炎相关肺部病变有所改善。
Intern Med. 2011;50(7):749-51. doi: 10.2169/internalmedicine.50.4748. Epub 2011 Apr 1.
3
Pulmonary complications of infliximab therapy in patients with rheumatoid arthritis.类风湿关节炎患者使用英夫利昔单抗治疗的肺部并发症
J Rheumatol. 2006 Mar;33(3):622-8.
4
[Pneumocystis pneumonia developed in two patients with rheumatoid arthritis during treatment of adalimumab].两名类风湿关节炎患者在接受阿达木单抗治疗期间发生了肺孢子菌肺炎。
Nihon Rinsho Meneki Gakkai Kaishi. 2011;34(5):420-5. doi: 10.2177/jsci.34.420.
5
Pneumocystis carinii pneumonia in a rheumatoid arthritis patient treated with adalimumab.一名使用阿达木单抗治疗的类风湿关节炎患者发生卡氏肺孢子虫肺炎。
Scand J Infect Dis. 2007;39(5):475-8. doi: 10.1080/00365540601071867.
6
Clinical characteristics and risk factors for Pneumocystis jirovecii pneumonia in patients with rheumatoid arthritis receiving adalimumab: a retrospective review and case-control study of 17 patients.类风湿关节炎患者接受阿达木单抗治疗后发生肺孢子菌肺炎的临床特征和危险因素:17 例患者的回顾性分析及病例对照研究。
Mod Rheumatol. 2013 Nov;23(6):1085-93. doi: 10.1007/s10165-012-0796-5. Epub 2012 Dec 5.
7
Miller-Fisher syndrome in a patient with rheumatoid arthritis treated with adalimumab.
Clin Rheumatol. 2009 Jan;28(1):93-4. doi: 10.1007/s10067-008-1017-7. Epub 2008 Sep 26.
8
Development of interstitial pneumonia in a rheumatoid arthritis patient treated with infliximab, an anti-tumor necrosis factor alpha-neutralizing antibody.一名接受抗肿瘤坏死因子α中和抗体英夫利昔单抗治疗的类风湿关节炎患者发生间质性肺炎。
Mod Rheumatol. 2006;16(4):251-5. doi: 10.1007/s10165-006-0491-5.
9
Acute exacerbation of preexisting interstitial lung disease after administration of etanercept for rheumatoid arthritis.类风湿关节炎患者使用依那西普治疗后,原有间质性肺疾病急性加重。
J Rheumatol. 2007 May;34(5):1151-4. Epub 2007 Apr 15.
10
Interstitial pneumonitis associated with infliximab therapy.英夫利昔单抗治疗相关的间质性肺炎
J Rheumatol. 2006 Jun;33(6):1189-93. Epub 2006 Apr 15.

引用本文的文献

1
Lung Involvement in Inflammatory Bowel Diseases: Shared Pathways and Unwanted Connections.炎症性肠病中的肺部受累:共同途径与不良关联
J Clin Med. 2023 Oct 9;12(19):6419. doi: 10.3390/jcm12196419.
2
A dose-dependent beneficial effect of methotrexate on the risk of interstitial lung disease in rheumatoid arthritis patients.甲氨蝶呤对类风湿关节炎患者间质性肺病风险具有剂量依赖性的有益作用。
PLoS One. 2021 Apr 16;16(4):e0250339. doi: 10.1371/journal.pone.0250339. eCollection 2021.
3
Treatment of Rheumatoid Arthritis-Associated Interstitial Lung Disease: Lights and Shadows.
类风湿关节炎相关间质性肺疾病的治疗:光明与阴影
J Clin Med. 2020 Apr 10;9(4):1082. doi: 10.3390/jcm9041082.
4
Adalimumab induced interstitial lung disease.阿达木单抗诱发的间质性肺病。
Respir Med Case Rep. 2020 Feb 1;29:101012. doi: 10.1016/j.rmcr.2020.101012. eCollection 2020.
5
Comprehensive review of current diagnostic and treatment approaches to interstitial lung disease associated with rheumatoid arthritis.类风湿关节炎相关间质性肺疾病的当前诊断与治疗方法综述
Eur J Rheumatol. 2018 Jul 1;6(3):146-149. doi: 10.5152/eurjrheum.2019.19036. Print 2019 Jul.
6
Effect of tumor necrosis factor inhibitors on interstitial lung disease in rheumatoid arthritis: angel or demon?肿瘤坏死因子抑制剂对类风湿关节炎间质性肺疾病的影响:天使还是魔鬼?
Drug Des Devel Ther. 2019 Jul 1;13:2111-2125. doi: 10.2147/DDDT.S204730. eCollection 2019.
7
Biologic Treatments in Interstitial Lung Diseases.间质性肺疾病的生物治疗
Front Med (Lausanne). 2019 Mar 13;6:41. doi: 10.3389/fmed.2019.00041. eCollection 2019.
8
Treatment of rheumatoid arthritis-associated interstitial lung disease: a perspective review.类风湿关节炎相关间质性肺疾病的治疗:一篇综述
Ther Adv Musculoskelet Dis. 2015 Dec;7(6):247-67. doi: 10.1177/1759720X15612250.
9
Management of Rheumatoid Arthritis Patients with Interstitial Lung Disease: Safety of Biological Antirheumatic Drugs and Assessment of Pulmonary Fibrosis.类风湿关节炎合并间质性肺疾病患者的管理:生物抗风湿药物的安全性及肺纤维化评估
Clin Med Insights Circ Respir Pulm Med. 2015 Sep 8;9(Suppl 1):41-9. doi: 10.4137/CCRPM.S23288. eCollection 2015.
10
Adalimumab-induced interstitial pneumonia in a patient with Crohn's disease.一名克罗恩病患者出现阿达木单抗诱导的间质性肺炎。
World J Gastroenterol. 2015 Feb 21;21(7):2260-2. doi: 10.3748/wjg.v21.i7.2260.